The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ciaffoni Joseph since 2018.
This trader's CIK number is 1443841.
At the time of last reporting, Ciaffoni Joseph was the Chief Executive Officer of Indivior Pharmaceuticals, Inc.. (stock ticker symbol INDV).
Also see all insider trading activities at Indivior Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | COLL | 0 | $0 | 209,462 | $5,254,614 | 84,375 | $1,739,361 |
| 2022 | COLL | 0 | $0 | 358,611 | $7,850,983 | 153,414 | $2,439,280 |
| 2021 | COLL | 0 | $0 | 64,768 | $1,485,130 | 48,616 | $399,623 |
| 2020 | COLL | 0 | $0 | 76,537 | $1,663,496 | 64,820 | $532,820 |
| 2019 | COLL | 0 | $0 | 78,108 | $1,371,248 | 64,821 | $532,828 |
| 2018 | COLL | 0 | $0 | 79,683 | $1,821,414 | 64,821 | $532,828 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | INDV | 0 | $0 | 0 | $0 | 1,266,903 | $0 |
1. Collegium Pharmaceutical, Inc (COLL)
2. Indivior Pharmaceuticals, Inc. (INDV)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-21 | COLL | Option Ex | 4,357 | 21.34 | 92,978 |
| 2023-12-21 | COLL | Sale | 4,357 | 30.38 | 132,378 |
| 2023-12-18 | COLL | Sale | 27,798 | 30.04 | 834,940 |
| 2023-12-18 | COLL | Option Ex | 27,798 | 21.34 | 593,209 |
| 2023-12-19 | COLL | Option Ex | 14,516 | 21.34 | 309,771 |
| 2023-12-20 | COLL | Option Ex | 26,454 | 21.34 | 564,528 |
| 2023-12-19 | COLL | Sale | 14,516 | 30.03 | 435,944 |
| 2023-12-20 | COLL | Sale | 26,454 | 30.40 | 804,201 |
| 2023-06-01 | COLL | Sale | 31,272 | 22.09 | 690,767 |
| 2023-06-02 | COLL | Sale | 31,272 | 21.91 | 685,294 |
| 2023-05-31 | COLL | Sale | 31,272 | 21.87 | 683,793 |
| 2023-05-30 | COLL | Sale | 31,271 | 21.90 | 684,897 |
| 2023-02-13 | COLL | Option Ex | 11,250 | 15.90 | 178,875 |
| 2023-02-13 | COLL | Sale | 11,250 | 26.88 | 302,400 |
| 2022-12-23 | COLL | Sale | 147 | 23.00 | 3,381 |
| 2022-12-22 | COLL | Sale | 110 | 23.00 | 2,530 |
| 2022-12-27 | COLL | Sale | 2,204 | 23.92 | 52,719 |
| 2022-12-19 | COLL | Sale | 1,134 | 23.01 | 26,093 |
| 2022-12-20 | COLL | Sale | 9,375 | 23.07 | 216,281 |
| 2022-12-21 | COLL | Sale | 7,333 | 23.11 | 169,465 |
| 2022-12-01 | COLL | Option Ex | 76,653 | 15.90 | 1,218,782 |
| 2022-12-01 | COLL | Sale | 76,653 | 22.47 | 1,722,392 |
| 2022-12-02 | COLL | Sale | 54,400 | 23.07 | 1,255,008 |
| 2022-12-01 | COLL | Option Ex | 76,653 | 15.90 | 1,218,782 |
| 2022-12-01 | COLL | Sale | 76,653 | 22.47 | 1,722,392 |
| 2022-12-02 | COLL | Sale | 54,400 | 23.07 | 1,255,008 |
| 2022-11-28 | COLL | Option Ex | 43 | 15.90 | 683 |
| 2022-11-28 | COLL | Sale | 43 | 22.00 | 946 |
| 2022-11-22 | COLL | Option Ex | 65 | 15.90 | 1,033 |
| 2022-11-22 | COLL | Sale | 65 | 22.00 | 1,430 |
| 2022-03-01 | COLL | Sale | 76,094 | 18.70 | 1,423,338 |
| 2021-03-01 | COLL | Option Ex | 48,616 | 8.22 | 399,623 |
| 2021-03-01 | COLL | Sale | 64,768 | 22.93 | 1,485,130 |
| 2020-06-01 | COLL | Option Ex | 64,820 | 8.22 | 532,820 |
| 2020-06-01 | COLL | Sale | 70,676 | 21.80 | 1,541,090 |
| 2020-06-02 | COLL | Sale | 5,861 | 20.89 | 122,406 |
| 2019-11-07 | COLL | Sale | 64,821 | 18.79 | 1,217,662 |
| 2019-11-07 | COLL | Option Ex | 64,821 | 8.22 | 532,828 |
| 2019-05-31 | COLL | Sale | 5,851 | 11.52 | 67,403 |
| 2019-06-03 | COLL | Sale | 7,436 | 11.59 | 86,183 |
| 2018-05-31 | COLL | Option Ex | 64,821 | 8.22 | 532,828 |
| 2018-06-01 | COLL | Sale | 14,862 | 22.48 | 334,097 |
| 2018-05-31 | COLL | Sale | 64,821 | 22.95 | 1,487,317 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-22 | INDV | Option Ex | 1,266,903 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ciaffoni Joseph (Chief Executive Officer of Indivior Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.